Advanced glycation end-products and advanced oxidation protein products in schizophrenia

Psychiatry Res. 2022 May:311:114527. doi: 10.1016/j.psychres.2022.114527. Epub 2022 Mar 22.

Abstract

Schizophrenia pathophysiology is still not well understood. Genetic factors involving biochemical systems are key players and oxidative stress takes part to the development and worsening of SZ. Oxidative stress led to the permanent production of oxidation products such as advanced glycation end products (AGEs) and advanced oxidation protein products (AOPPs). These proteins interact with their receptor amplifying ROS production and pro-inflammatory cytokines sustaining a permanent loop. We tested plasma levels of AGEs and AOPPs in 30 SZ patients. Their levels were statistically higher than controls confirming their involvement in mental disorders. Antioxidant nutraceuticals and a healthy lifestyle could diminish oxidative stress and ameliorate SZ symptoms.

Keywords: Antioxidants; Oxidative stress; Schizophrenia.

MeSH terms

  • Advanced Oxidation Protein Products*
  • Biomarkers
  • Glycation End Products, Advanced / metabolism
  • Humans
  • Oxidative Stress
  • Schizophrenia*

Substances

  • Advanced Oxidation Protein Products
  • Biomarkers
  • Glycation End Products, Advanced